Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy
Diabetic angiopathy, a major complication of type 2 diabetes mellitus (T2DM), is driven by vascular dysfunction, metabolic reprogramming, and oxidative stress. NAD+-dependent deacetylase SIRT6, located in the nucleus, is recognized for its role in modulating cardiovascular and metabolic homeostasis...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Redox Biology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725002496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227042900410368 |
|---|---|
| author | Kemiao Pang Jiayi Huang Shiwu Zhang Yinghui Guan Ning Zou Jiaxin Kang Haining Du Dechao Zhao Denis V. Abramochkin Heyu Chen Nan Zhang Yunyan Gu Ning Liu Yining Niu Ziqi Xiong Xueya Zhang Fanghao Lu Huitao Fan Jinwei Tian Bo Yu Shuijie Li Weihua Zhang |
| author_facet | Kemiao Pang Jiayi Huang Shiwu Zhang Yinghui Guan Ning Zou Jiaxin Kang Haining Du Dechao Zhao Denis V. Abramochkin Heyu Chen Nan Zhang Yunyan Gu Ning Liu Yining Niu Ziqi Xiong Xueya Zhang Fanghao Lu Huitao Fan Jinwei Tian Bo Yu Shuijie Li Weihua Zhang |
| author_sort | Kemiao Pang |
| collection | DOAJ |
| description | Diabetic angiopathy, a major complication of type 2 diabetes mellitus (T2DM), is driven by vascular dysfunction, metabolic reprogramming, and oxidative stress. NAD+-dependent deacetylase SIRT6, located in the nucleus, is recognized for its role in modulating cardiovascular and metabolic homeostasis through histone deacetylation. However, the functions and mechanisms of accumulation of cytoplasmic SIRT6 in T2DM remain to be elucidated. Herein, a previously unrecognized cytoplasmic role for SIRT6 is identified in promoting pathological glycolysis during diabetic vascular remodeling. Vascular smooth muscle cell (VSMC) proliferation is observed, which is correlated with protein deacetylation, especially SIRT6, which translocated to the cytoplasm mediated by Importin 13 (IPO13). Furthermore, the accumulation of cytoplasmic SIRT6 facilitates its interaction with enolase 3 (ENO3), a newly discovered downstream target. This interaction promotes ENO3 deacetylation, enhances downstream phosphoenolpyruvic acid (PEP) levels, and thereby drives glycolysis reprogramming, ultimately leading to the pathological changes associated with diabetic angiopathy. Notably, exogenous hydrogen sulfide (H2S) restores S-sulfhydration of SIRT6 at cysteine 141, counteracting the SIRT6-ENO3 interaction, suppressing glycolysis, and mitigating VSMC hyperproliferation. This study provides novel insights into the SIRT6-ENO3 pathway through regulating vascular glycolysis reprogramming, highlighting the therapeutic potential of targeting SIRT6 in the management of diabetic angiopathy. |
| format | Article |
| id | doaj-art-e165ce853d9d495683bf74ae227acaf8 |
| institution | Kabale University |
| issn | 2213-2317 |
| language | English |
| publishDate | 2025-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Redox Biology |
| spelling | doaj-art-e165ce853d9d495683bf74ae227acaf82025-08-24T05:12:24ZengElsevierRedox Biology2213-23172025-09-018510373610.1016/j.redox.2025.103736Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathyKemiao Pang0Jiayi Huang1Shiwu Zhang2Yinghui Guan3Ning Zou4Jiaxin Kang5Haining Du6Dechao Zhao7Denis V. Abramochkin8Heyu Chen9Nan Zhang10Yunyan Gu11Ning Liu12Yining Niu13Ziqi Xiong14Xueya Zhang15Fanghao Lu16Huitao Fan17Jinwei Tian18Bo Yu19Shuijie Li20Weihua Zhang21Department of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Vascular Surgery, First Affiliated Hospital of Harbin Medical University, ChinaCenter for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, First Affiliated Hospital of Harbin Medical University, ChinaDepartment of Human and Animal Physiology, Biological Faculty, Lomonosov Moscow State University, RussiaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaDepartment of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, ChinaNHC Key Laboratory of Cell Transplantation, The First Affiliated Hospital of Harbin Medical University, China; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, China; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, China; Corresponding author. Department of Hematology, The First Affiliated Hospital of Harbin Medical University, China.Department of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, China; Heilongjiang Provincial Key Laboratory of Panvascular Disease, China; Corresponding author. Department of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, China.Department of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, China; State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), China; Corresponding authors. State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), China.State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), China; Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, China; Heilongjiang Province Key Laboratory of Research on Molecular Targeted Antitumor Drugs, China; Corresponding authors. State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), China.Department of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, China; Heilongjiang Provincial Key Laboratory of Panvascular Disease, China; Corresponding authors. Department of Cardiology, Department of Pathophysiology, Key Laboratory of Myocardial Ischemia, Ministry of Education, Second Affiliated Hospital of Harbin Medical University, China.Diabetic angiopathy, a major complication of type 2 diabetes mellitus (T2DM), is driven by vascular dysfunction, metabolic reprogramming, and oxidative stress. NAD+-dependent deacetylase SIRT6, located in the nucleus, is recognized for its role in modulating cardiovascular and metabolic homeostasis through histone deacetylation. However, the functions and mechanisms of accumulation of cytoplasmic SIRT6 in T2DM remain to be elucidated. Herein, a previously unrecognized cytoplasmic role for SIRT6 is identified in promoting pathological glycolysis during diabetic vascular remodeling. Vascular smooth muscle cell (VSMC) proliferation is observed, which is correlated with protein deacetylation, especially SIRT6, which translocated to the cytoplasm mediated by Importin 13 (IPO13). Furthermore, the accumulation of cytoplasmic SIRT6 facilitates its interaction with enolase 3 (ENO3), a newly discovered downstream target. This interaction promotes ENO3 deacetylation, enhances downstream phosphoenolpyruvic acid (PEP) levels, and thereby drives glycolysis reprogramming, ultimately leading to the pathological changes associated with diabetic angiopathy. Notably, exogenous hydrogen sulfide (H2S) restores S-sulfhydration of SIRT6 at cysteine 141, counteracting the SIRT6-ENO3 interaction, suppressing glycolysis, and mitigating VSMC hyperproliferation. This study provides novel insights into the SIRT6-ENO3 pathway through regulating vascular glycolysis reprogramming, highlighting the therapeutic potential of targeting SIRT6 in the management of diabetic angiopathy.http://www.sciencedirect.com/science/article/pii/S2213231725002496Type 2 diabetes (T2D)Cell proliferationSirtuin 6 (SIRT6)Hydrogen sulfide (H2S)Glycolysis |
| spellingShingle | Kemiao Pang Jiayi Huang Shiwu Zhang Yinghui Guan Ning Zou Jiaxin Kang Haining Du Dechao Zhao Denis V. Abramochkin Heyu Chen Nan Zhang Yunyan Gu Ning Liu Yining Niu Ziqi Xiong Xueya Zhang Fanghao Lu Huitao Fan Jinwei Tian Bo Yu Shuijie Li Weihua Zhang Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy Redox Biology Type 2 diabetes (T2D) Cell proliferation Sirtuin 6 (SIRT6) Hydrogen sulfide (H2S) Glycolysis |
| title | Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy |
| title_full | Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy |
| title_fullStr | Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy |
| title_full_unstemmed | Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy |
| title_short | Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy |
| title_sort | translocation of sirt6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy |
| topic | Type 2 diabetes (T2D) Cell proliferation Sirtuin 6 (SIRT6) Hydrogen sulfide (H2S) Glycolysis |
| url | http://www.sciencedirect.com/science/article/pii/S2213231725002496 |
| work_keys_str_mv | AT kemiaopang translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT jiayihuang translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT shiwuzhang translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT yinghuiguan translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT ningzou translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT jiaxinkang translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT hainingdu translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT dechaozhao translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT denisvabramochkin translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT heyuchen translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT nanzhang translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT yunyangu translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT ningliu translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT yiningniu translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT ziqixiong translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT xueyazhang translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT fanghaolu translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT huitaofan translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT jinweitian translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT boyu translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT shuijieli translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy AT weihuazhang translocationofsirt6promotesglycolysisreprogrammingtoexacerbatediabeticangiopathy |